Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFLOAT: Flecainide to Prevent Atrial Arrhythmia After PFO Closure
NCT05213104Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flecainide in atrial arrhythmia, sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2022; status: active, not recruiting.
02
Drugs
flecainide
03
Conditions
atrial arrhythmia
Beyond the preview
Go deeper on NCT05213104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213104.